Molecular basis for JAK2 inhibition with type II compounds.

Abstract Poster

Authors

null

Dafne Jacome

Tampere University, Tampere, Finland

Dafne Jacome , Ya Miao , Teemu Haikarainen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Breakthrough

Session Type

Poster Session

Session Title

Poster Session B

Track

Thoracic Cancers,Breast Cancer,Gynecologic Cancer,Head and Neck Cancer,Hematologic Malignancies,Genetics/Genomics/Multiomics,Healthtech Innovations,Models of Care and Care Delivery,Viral-Mediated Malignancies,Other Malignancies or Topics

Sub Track

Other Technology and Innovations

Citation

J Clin Oncol 42, 2024 (suppl 23; abstr 176)

DOI

10.1200/JCO.2024.42.23_suppl.176

Abstract #

176

Poster Bd #

G7

Abstract Disclosures

Similar Posters

First Author: Ciro Roberto Rinaldi

First Author: Peter P. Sayeski

Poster

2024 ASCO Annual Meeting

Outcomes of patients with bone marrow fibrosis in de novo and secondary acute myeloid leukemia.

Outcomes of patients with bone marrow fibrosis in de novo and secondary acute myeloid leukemia.

First Author: Samuel Urrutia

First Author: Marine Gross-Goupil